相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research

Author Spotlight: Innovating Thiol Quantification and Biomarker Detection for Oxidative Stress Research

Published on: June 28, 2024

谷氨作为治疗OxLDL诱导的内皮功能障碍和动脉样硬化预防的治疗剂

Chathuri Kaushalya Marasinghe¹, Jae-Young Je²

¹Department of Food and Life Science, Pukyong National University, Busan, South Korea.

Cell biology international

|June 13, 2025

概括

减少的谷氨 (GSH) 能保护氧化低密度脂蛋白 (oxLDL) 诱导的内皮功能障碍. 维生素维生素维护细胞活力,减少氧化应激和炎症,并防止细胞亡,为动脉样硬化预防提供了潜在的可能性.

科学领域:

心血管生物学心血管生物学
细胞和分子医学细胞和分子医学
氧化压力研究研究氧化压力研究

背景情况:

由氧化低密度脂蛋白 (oxLDL) 驱动的内皮功能障碍是动脉样硬化和心血管疾病的核心.
氧化应激和炎症是oxLDL诱导的内皮损伤的关键机制.

研究的目的:

研究减少的谷氨 (GSH) 对人类脉内皮细胞 (HUVECs) 中的oxLDL诱导的内皮功能障碍的保护作用.

主要方法:

使用了暴露于oxLDL的HUVEC体外模型.
评估了细胞活力,氧化应激标志物 (ROS,脂质过氧化),氧化 (NO) 生产和eNOS活性.
评估了抗氧化酶水平 (SOD,甲酶,GPx),亡标志物 (Bax/Bcl-2,caspase-3) 和炎症标志物 (ICAM-1,VCAM-1). 这些都在研究中.

主要成果:

暴露在OxLDL下降了HUVEC活力,增加了氧化应激,并通过上调LOX-1和降低eNOS活性来降低NO生产.
通过保持eNOS活性,GSH预处理恢复了细胞活力,减少了ROS和脂质过氧化,并保持了NO的生物可用性.
通过降低粘附分子的调节,GSH增强了抗氧化防御,抑制了亡,并减轻了炎症.

结论:

降低的谷氨 (GSH) 显示出对抗oxLDL诱导的内皮功能障碍的显著保护作用.
GSH可以缓解氧化应激,亡和炎症,突出显示其在预防动脉样硬化进展方面的治疗潜力.

关键词:

中心发电系统 (CVD) 是一种动脉样硬化动脉样硬化内皮质功能障碍在内皮质功能障碍 oxLDL oxLDL 的意思是什么?减少了GSH的发生.

更多相关视频

The Cell-based L-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins

The Cell-based L-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins

Published on: December 13, 2013

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

相关概念视频

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Phase I Oxidative Reactions: Overview

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...